EWTX
Edgewise Therapeutics, Inc.
Company overview
- Market capitalization
- $4.32B
- Employees
- 154
- Latest publication
- 2026-09-29
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials; and EDG-15400, a novel small molecule for the treatment of heart failure with preserved ejection fraction. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 2,118,000USD | 0USD | 0USD |
| Cost Of Revenue | 590,000USD | — | — | 567,000USD | 554,000USD | 1,059,000USD | 2,290,000USD | 534,000USD |
| Gross Profit | -590,000USD | — | — | -567,000USD | -554,000USD | 1,059,000USD | -2,290,000USD | -534,000USD |
| Research Development | 42,651,000USD | 43,594,000USD | 37,480,000USD | 33,558,000USD | 36,757,000USD | 36,370,000USD | 32,222,000USD | 30,680,000USD |
| Selling General Administrative | 11,464,000USD | 12,385,000USD | 9,378,000USD | 9,052,000USD | 9,202,000USD | 9,170,000USD | 8,210,000USD | 7,427,000USD |
| Total Operating Expenses | 53,525,000USD | 55,979,000USD | 46,858,000USD | 42,610,000USD | 45,959,000USD | 45,540,000USD | 40,432,000USD | 38,107,000USD |
| Operating Income | -54,115,000USD | -55,979,000USD | -46,858,000USD | -42,610,000USD | -45,959,000USD | -45,540,000USD | -40,432,000USD | -38,107,000USD |
| Interest Income | 5,102,000USD | 5,763,000USD | 6,192,000USD | 6,495,000USD | 5,161,000USD | 5,878,000USD | 6,303,000USD | 6,610,000USD |
| Net Interest Income | 5,102,000USD | 5,763,000USD | 6,192,000USD | 6,495,000USD | 5,161,000USD | 5,878,000USD | 6,303,000USD | 6,610,000USD |
| Income Before Tax | -49,013,000USD | -50,216,000USD | -40,666,000USD | -36,115,000USD | -40,798,000USD | -39,662,000USD | -34,129,000USD | -31,497,000USD |
| Net Income | -49,013,000USD | -50,216,000USD | -40,666,000USD | -36,115,000USD | -40,798,000USD | -39,662,000USD | -34,129,000USD | -31,497,000USD |
| Net Income From Continuing Ops | -49,013,000USD | -50,216,000USD | -40,666,000USD | -36,115,000USD | -40,798,000USD | -39,662,000USD | -34,129,000USD | -31,497,000USD |
| Ebit | -49,013,000USD | -50,216,000USD | -40,666,000USD | -36,115,000USD | -40,798,000USD | -39,662,000USD | -34,129,000USD | -31,497,000USD |
| Ebitda | -48,423,000USD | -51,860,000USD | -40,143,000USD | -35,548,000USD | -40,244,000USD | -39,033,000USD | -33,527,000USD | -30,963,000USD |
| Depreciation And Amortization | 590,000USD | -1,644,000USD | 523,000USD | 567,000USD | 554,000USD | 629,000USD | 602,000USD | 534,000USD |
| Reconciled Depreciation | 590,000USD | 575,000USD | 570,000USD | 567,000USD | 554,000USD | 629,000USD | 602,000USD | 534,000USD |
| Total Other Income Expense Net | 5,102,000USD | 5,763,000USD | 6,192,000USD | 6,495,000USD | 5,161,000USD | 5,878,000USD | 6,303,000USD | 6,610,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 106,000USD | — | 54,000USD |
| Income Tax Expense | — | — | — | — | — | -481,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,266,000USD | 2,290,000USD | 1,732,000USD | 538,000USD | 272,000USD | 185,000USD | 123,000USD |
| Gross Profit | -2,266,000USD | -2,290,000USD | -1,732,000USD | -538,000USD | -272,000USD | -185,000USD | -123,000USD |
| Research Development | 151,389,000USD | 126,966,000USD | 90,905,000USD | 16,612,000USD | 32,189,000USD | 14,798,000USD | 8,624,000USD |
| Selling General Administrative | 40,017,000USD | 31,866,000USD | 23,452,000USD | 5,467,000USD | 11,026,000USD | 2,209,000USD | 1,300,000USD |
| Unclassified Operating Expenses | -2,266,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 189,140,000USD | 158,832,000USD | 114,357,000USD | 22,079,000USD | 43,215,000USD | 17,007,000USD | 9,924,000USD |
| Operating Income | -191,406,000USD | -158,832,000USD | -114,357,000USD | -22,079,000USD | -43,215,000USD | -17,192,000USD | -9,924,000USD |
| Interest Income | 23,611,000USD | 25,019,000USD | 14,194,000USD | 4,018,000USD | 402,000USD | 69,000USD | 219,000USD |
| Net Interest Income | 23,611,000USD | 25,019,000USD | 14,194,000USD | 4,018,000USD | 402,000USD | 69,000USD | 219,000USD |
| Income Before Tax | -167,795,000USD | -133,813,000USD | -100,163,000USD | -19,415,000USD | -42,813,000USD | -17,123,000USD | -9,705,000USD |
| Net Income | -167,795,000USD | -133,813,000USD | -100,163,000USD | -15,397,000USD | -42,139,000USD | -17,054,000USD | -9,486,000USD |
| Net Income From Continuing Ops | -167,795,000USD | -133,813,000USD | -100,163,000USD | -67,640,000USD | -42,813,000USD | -17,123,000USD | -9,705,000USD |
| Ebit | -167,795,000USD | -133,813,000USD | -100,163,000USD | -22,079,000USD | -43,215,000USD | -17,192,000USD | -9,924,000USD |
| Ebitda | -165,529,000USD | -131,523,000USD | -98,431,000USD | -21,541,000USD | -42,943,000USD | -17,007,000USD | -9,801,000USD |
| Depreciation And Amortization | 2,266,000USD | 2,290,000USD | 1,732,000USD | 538,000USD | 272,000USD | 185,000USD | 123,000USD |
| Reconciled Depreciation | 2,266,000USD | 2,290,000USD | 1,732,000USD | 538,000USD | 272,000USD | 185,000USD | 123,000USD |
| Total Other Income Expense Net | 23,611,000USD | 25,019,000USD | 14,194,000USD | 2,664,000USD | 402,000USD | 69,000USD | 219,000USD |
| Income Tax Expense | — | -1USD | — | -4,018,000USD | -674,000USD | -69,000USD | -219,000USD |
| Selling And Marketing Expenses | — | — | 181,000USD | — | — | — | — |
| Interest Expense | — | — | — | 4,018,000USD | 272,000USD | 69,000USD | 0USD |
| Non Operating Income Net Other | — | — | — | 4,018,000USD | 402,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -67,640,000USD | -42,813,000USD | -17,123,000USD | -9,705,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 479,688,000USD | 518,522,000USD | 552,603,000USD | 583,466,000USD | 613,334,000USD | 454,391,000USD | 486,817,000USD | 511,282,000USD |
| Cash And Equivalents | 72,319,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 471,518,000USD | 509,792,000USD | 543,385,000USD | 573,900,000USD | 603,255,000USD | 443,178,000USD | 475,483,000USD | 499,436,000USD |
| Other Current Assets | 6,445,000USD | 10,230,000USD | 13,276,000USD | 10,560,000USD | 9,263,000USD | 6,791,000USD | 5,313,000USD | 6,900,000USD |
| Total Liabilities | 31,611,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 29,042,000USD | 22,543,000USD | 27,370,000USD | 21,646,000USD | 20,896,000USD | 21,115,000USD | 23,860,000USD | 18,957,000USD |
| Other Current Liabilities | 5,189,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 448,077,000USD | 493,203,000USD | 522,257,000USD | 558,647,000USD | 589,071,000USD | 429,719,000USD | 459,216,000USD | 488,877,000USD |
| Total Equity Including Noncontrolling Interest | 448,077,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 8,170,000USD | 8,730,000USD | 9,218,000USD | 9,566,000USD | 10,079,000USD | 10,518,000USD | 11,072,000USD | 11,584,000USD |
| Accounts Payable | 4,666,000USD | 7,293,000USD | 6,006,000USD | 6,157,000USD | 8,320,000USD | 8,789,000USD | 5,579,000USD | 5,649,000USD |
| Short Term Debt | 1,021,000USD | 1,017,000USD | 1,014,000USD | 1,008,000USD | 1,004,000USD | 1,001,000USD | 996,000USD | 992,000USD |
| Common Stock | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD |
| Retained Earnings | -652,711,000USD | -595,384,000USD | -546,371,000USD | -496,155,000USD | -455,489,000USD | -419,374,000USD | -378,576,000USD | -338,914,000USD |
| Accumulated Other Comprehensive Income | -500,000USD | -252,000USD | 677,000USD | 701,000USD | 204,000USD | 401,000USD | 420,000USD | 1,051,000USD |
| Total Liab | — | 25,319,000USD | 30,346,000USD | 24,819,000USD | 24,263,000USD | 24,672,000USD | 27,601,000USD | 22,405,000USD |
| Other Current Liab | — | 14,233,000USD | 20,350,000USD | 14,481,000USD | 11,572,000USD | 11,325,000USD | 17,285,000USD | 12,316,000USD |
| Capital Stock | — | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD | 9,000USD |
| Cash | — | 33,211,000USD | 61,148,000USD | 46,003,000USD | 43,404,000USD | 49,921,000USD | 41,666,000USD | 44,806,000USD |
| Cash And Short Term Investments | — | 499,562,000USD | 530,109,000USD | 563,340,000USD | 593,992,000USD | 436,387,000USD | 470,170,000USD | 492,536,000USD |
| Net Debt | — | -29,418,000USD | -57,158,000USD | -41,822,000USD | -39,033,000USD | -45,363,000USD | -36,929,000USD | -40,366,000USD |
| Short Long Term Debt Total | — | 3,793,000USD | 3,990,000USD | 4,181,000USD | 4,371,000USD | 4,558,000USD | 4,737,000USD | 4,440,000USD |
| Short Term Investments | — | 466,351,000USD | 468,961,000USD | 517,337,000USD | 550,588,000USD | 386,466,000USD | 428,504,000USD | 447,730,000USD |
| Property Plant Equipment Gross | — | 16,036,000USD | 15,987,000USD | 15,810,000USD | 15,800,000USD | 15,716,000USD | 15,757,000USD | 15,692,000USD |
| Common Stock Shares Outstanding | — | 107,116,709shares | 102,930,744shares | 105,492,779shares | 104,940,493shares | 95,130,053shares | 92,414,626shares | 93,813,346shares |
| Non Current Assets Total | — | 8,730,000USD | 9,218,000USD | 9,566,000USD | 10,079,000USD | 11,213,000USD | 11,334,000USD | 11,846,000USD |
| Non Current Liabilities Total | — | 2,776,000USD | 2,976,000USD | 3,173,000USD | 3,367,000USD | 3,557,000USD | 3,741,000USD | 3,448,000USD |
| Net Working Capital | — | 487,249,000USD | 516,015,000USD | 552,254,000USD | 582,359,000USD | 422,063,000USD | 451,623,000USD | 480,479,000USD |
| Unclassified Non Current Liabilities | — | 2,776,000USD | 2,976,000USD | 3,173,000USD | 3,367,000USD | 3,557,000USD | 3,741,000USD | 3,448,000USD |
| Unclassified Equity | — | 1,088,819,000USD | 1,067,931,000USD | 1,054,081,000USD | 1,044,336,000USD | 848,674,000USD | 837,354,000USD | 826,722,000USD |
| Non Currrent Assets Other | — | — | — | — | — | 695,000USD | 262,000USD | 262,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 552,603,000USD | 486,817,000USD | 340,035,000USD | 367,101,000USD | 285,233,000USD | 131,136,000USD | 24,541,000USD |
| Other Current Assets | 13,276,000USD | 5,313,000USD | 8,604,000USD | 5,052,000USD | 2,984,000USD | 551,000USD | 390,000USD |
| Total Liab | 30,346,000USD | 27,601,000USD | 21,205,000USD | 20,385,000USD | 10,850,000USD | 164,556,000USD | 41,394,000USD |
| Total Stockholder Equity | 522,257,000USD | 459,216,000USD | 318,830,000USD | 346,716,000USD | 274,383,000USD | -33,420,000USD | -16,853,000USD |
| Other Current Liab | 20,350,000USD | 17,285,000USD | 11,766,000USD | 9,872,000USD | 6,678,000USD | 2,762,000USD | 465,000USD |
| Common Stock | 10,000USD | 9,000USD | 7,000USD | 6,000USD | 5,000USD | — | — |
| Capital Stock | 10,000USD | 9,000USD | 7,000USD | 6,000USD | 5,000USD | 0USD | 0USD |
| Retained Earnings | -546,371,000USD | -378,576,000USD | -244,763,000USD | -144,600,000USD | -76,960,000USD | -34,147,000USD | -17,024,000USD |
| Cash | 61,148,000USD | 41,666,000USD | 86,097,000USD | 21,993,000USD | 15,566,000USD | 104,916,000USD | 23,653,000USD |
| Cash And Short Term Investments | 530,109,000USD | 470,170,000USD | 318,393,000USD | 351,947,000USD | 280,789,000USD | 129,094,000USD | 23,653,000USD |
| Total Current Assets | 543,385,000USD | 475,483,000USD | 326,997,000USD | 356,999,000USD | 283,773,000USD | 129,645,000USD | 24,043,000USD |
| Total Current Liabilities | 27,370,000USD | 23,860,000USD | 16,771,000USD | 16,585,000USD | 10,521,000USD | 4,342,000USD | 1,132,000USD |
| Net Debt | -57,158,000USD | -36,929,000USD | -80,683,000USD | -17,585,000USD | -15,566,000USD | 55,298,000USD | -23,653,000USD |
| Short Term Debt | 1,014,000USD | 996,000USD | 980,000USD | 608,000USD | — | — | — |
| Short Long Term Debt Total | 3,990,000USD | 4,737,000USD | 5,414,000USD | 4,408,000USD | — | 160,214,000USD | 40,262,000USD |
| Short Term Investments | 468,961,000USD | 428,504,000USD | 232,296,000USD | 329,954,000USD | 265,223,000USD | 24,178,000USD | 0USD |
| Accounts Payable | 6,006,000USD | 5,579,000USD | 4,025,000USD | 6,105,000USD | 3,843,000USD | 1,580,000USD | 667,000USD |
| Property Plant Equipment Net | 9,218,000USD | 11,072,000USD | 12,690,000USD | 9,851,000USD | 912,000USD | 516,000USD | 498,000USD |
| Property Plant Equipment Gross | 15,987,000USD | 15,757,000USD | 15,306,000USD | 8,533,000USD | 912,000USD | 516,000USD | 498,000USD |
| Accumulated Other Comprehensive Income | 677,000USD | 420,000USD | 99,000USD | -1,355,000USD | -514,000USD | -430,000USD | -245,000USD |
| Common Stock Shares Outstanding | 102,930,744shares | 92,414,626shares | 63,723,600shares | 53,593,753shares | 49,500,308shares | 49,217,048shares | 49,217,048shares |
| Non Current Assets Total | 9,218,000USD | 11,334,000USD | 13,038,000USD | 10,102,000USD | 1,460,000USD | 1,491,000USD | 498,000USD |
| Non Current Liabilities Total | 2,976,000USD | 3,741,000USD | 4,434,000USD | 3,800,000USD | 329,000USD | 160,214,000USD | 40,262,000USD |
| Net Working Capital | 516,015,000USD | 451,623,000USD | 310,226,000USD | 340,414,000USD | 273,252,000USD | 125,303,000USD | 22,911,000USD |
| Unclassified Non Current Liabilities | 2,976,000USD | 3,741,000USD | 4,434,000USD | 3,549,000USD | — | 159,514,000USD | 40,262,000USD |
| Unclassified Equity | 1,067,931,000USD | 837,354,000USD | 563,480,000USD | 492,659,000USD | 351,847,000USD | 1,157,000USD | — |
| Non Currrent Assets Other | — | 262,000USD | 348,000USD | 251,000USD | 548,000USD | 975,000USD | — |
| Deferred Long Term Liab | — | — | — | 251,000USD | — | 700,000USD | — |
| Other Assets | — | — | — | 251,000USD | 548,000USD | 975,000USD | — |
| Net Receivables | — | — | — | 251,000USD | 548,000USD | — | — |
| Net Tangible Assets | — | — | — | 346,716,000USD | 274,383,000USD | -33,420,000USD | -16,853,000USD |
| Other Liab | — | — | — | — | 329,000USD | — | — |
| Non Current Liabilities Other | — | — | — | — | 329,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -49,013,000USD | -40,666,000USD | -36,115,000USD | -40,798,000USD | -39,662,000USD | -34,129,000USD | -31,497,000USD | -28,525,000USD |
| Depreciation | 590,000USD | 570,000USD | 567,000USD | 554,000USD | 629,000USD | 602,000USD | 534,000USD | 525,000USD |
| Stock Based Compensation | 8,715,000USD | 8,085,000USD | 7,733,000USD | 9,059,000USD | 7,737,000USD | 6,880,000USD | 5,224,000USD | 4,871,000USD |
| Other Non Cash Items | -1,013,000USD | -2,056,000USD | -2,203,000USD | -1,923,000USD | -2,602,000USD | -3,240,000USD | -3,553,000USD | -3,150,000USD |
| Change In Working Capital | -1,822,000USD | -709,000USD | -2,564,000USD | -4,758,000USD | 6,941,000USD | 2,513,000USD | 3,193,000USD | -2,319,000USD |
| Total Cash From Operating Activities | -42,543,000USD | -34,776,000USD | -32,582,000USD | -37,866,000USD | -26,957,000USD | -27,374,000USD | -26,099,000USD | -28,598,000USD |
| Capital Expenditures | -260,000USD | -89,000USD | -50,000USD | -44,000USD | -274,000USD | -520,000USD | -221,000USD | -297,000USD |
| Free Cash Flow | -42,803,000USD | -34,865,000USD | -32,632,000USD | -37,910,000USD | -27,231,000USD | -27,894,000USD | -26,320,000USD | -28,895,000USD |
| Investments | 2,693,000USD | 35,716,000USD | -162,166,000USD | 43,898,000USD | 20,922,000USD | 25,362,000USD | 37,368,000USD | -268,308,000USD |
| Total Cashflows From Investing Activities | 2,433,000USD | 35,716,000USD | -162,166,000USD | 43,898,000USD | 20,922,000USD | 25,362,000USD | 37,368,000USD | -268,308,000USD |
| Total Cash From Financing Activities | 12,173,000USD | 1,659,000USD | 188,231,000USD | 2,223,000USD | 2,895,000USD | 3,333,000USD | 1,952,000USD | 241,073,000USD |
| Change In Cash | -27,937,000USD | 2,599,000USD | -6,517,000USD | 8,255,000USD | -3,140,000USD | 1,321,000USD | 13,221,000USD | -55,833,000USD |
| Begin Period Cash Flow | 61,148,000USD | 43,404,000USD | 49,921,000USD | 41,666,000USD | 44,806,000USD | 43,485,000USD | 30,264,000USD | 86,097,000USD |
| End Period Cash Flow | 33,211,000USD | 46,003,000USD | 43,404,000USD | 49,921,000USD | 41,666,000USD | 44,806,000USD | 43,485,000USD | 30,264,000USD |
| Issuance Of Capital Stock | — | 0USD | 187,362,000USD | 0USD | 0USD | 0USD | 0USD | 239,147,000USD |
| Other Cashflows From Investing Activities | — | 35,805,000USD | — | — | — | — | 37,589,000USD | -268,011,000USD |
| Other Cashflows From Financing Activities | — | 1,659,000USD | 869,000USD | 2,223,000USD | -262,000USD | 48,000USD | -48,000USD | 1,926,000USD |
| Unclassified Investing Cash Flow | — | -35,716,000USD | — | — | — | — | -37,368,000USD | 268,308,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | 3,157,000USD | 3,285,000USD | 2,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -167,795,000USD | -133,813,000USD | -100,163,000USD | -42,813,000USD | -17,123,000USD | -9,705,000USD |
| Depreciation | 2,266,000USD | 2,290,000USD | 1,732,000USD | 272,000USD | 185,000USD | 123,000USD |
| Stock Based Compensation | 34,752,000USD | 24,712,000USD | 17,560,000USD | 4,404,000USD | 354,000USD | 77,000USD |
| Other Non Cash Items | -7,665,000USD | -12,545,000USD | -9,517,000USD | 2,294,000USD | 203,000USD | 48,000USD |
| Change In Working Capital | -5,374,000USD | 10,328,000USD | -1,560,000USD | 4,630,000USD | 1,950,000USD | 334,000USD |
| Total Cash From Operating Activities | -143,816,000USD | -109,028,000USD | -91,948,000USD | -33,507,000USD | -14,634,000USD | -9,171,000USD |
| Capital Expenditures | -256,000USD | -1,312,000USD | -5,745,000USD | -668,000USD | -203,000USD | -180,000USD |
| Free Cash Flow | -143,816,000USD | -110,340,000USD | -97,693,000USD | -34,175,000USD | -14,837,000USD | -9,351,000USD |
| Investments | -32,534,000USD | -184,656,000USD | 307,000USD | -241,559,000USD | -24,178,000USD | -24,178,000USD |
| Total Cashflows From Investing Activities | -32,790,000USD | -184,656,000USD | 102,886,000USD | -242,227,000USD | -24,381,000USD | -180,000USD |
| Total Cash From Financing Activities | 196,088,000USD | 249,253,000USD | 53,166,000USD | 186,384,000USD | 120,278,000USD | 24,800,000USD |
| Issuance Of Capital Stock | 187,362,000USD | 239,147,000USD | -555,000USD | 186,148,000USD | 120,076,000USD | 24,778,000USD |
| Change In Cash | 19,482,000USD | -44,431,000USD | 64,104,000USD | -89,350,000USD | 81,263,000USD | 15,449,000USD |
| Begin Period Cash Flow | 41,666,000USD | 86,097,000USD | 21,993,000USD | 104,916,000USD | 23,653,000USD | 8,204,000USD |
| End Period Cash Flow | 61,148,000USD | 41,666,000USD | 86,097,000USD | 15,566,000USD | 104,916,000USD | 23,653,000USD |
| Other Cashflows From Investing Activities | -32,790,000USD | — | — | -241,559USD | -24,178USD | — |
| Other Cashflows From Financing Activities | 196,088,000USD | 10,106,000USD | 548,000USD | 236,000USD | 120,278,000USD | 24,800,000USD |
| Unclassified Investing Cash Flow | 32,790,000USD | — | 108,324,000USD | — | — | 24,178,000USD |
| Unclassified Financing Cash Flow | -187,362,000USD | — | 53,173,000USD | — | -120,076,000USD | -24,778,000USD |
| Change To Liabilities | — | — | — | 7,022,000USD | 521,000USD | 275,000USD |
| Sale Purchase Of Stock | — | — | — | 186,384,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -89,350,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | -2,294,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.